Filter
8137
Filtered Results: 8137
Text search:
drugs
act
Featured
Recommendations
685
New Publications
2013
Language
Document type
No document type
4676
Studies & Reports
1260
Guidelines
1073
Manuals
395
Strategic & Response Plan
259
Fact sheets
189
Training Material
147
Situation Updates
38
Infographics
36
Brochures
28
Resource Platforms
24
Online Courses
8
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
470
Global
291
Kenya
231
South Africa
188
Uganda
164
Ethiopia
161
Nigeria
156
Western and Central Europe
154
Nepal
142
Sierra Leone
142
Tanzania
124
Zambia
121
Latin America and the Carribbean
119
Liberia
119
Africa
115
Malawi
114
Ghana
104
Bangladesh
99
Rwanda
98
Myanmar / Burma
97
Ukraine
87
Namibia
80
Eastern Europe
75
Philippines
65
Zimbabwe
58
Congo, Democratic Republic of
57
Asia
55
Russia
54
Senegal
51
South–East Asia Region
51
Indonesia
51
Syria
47
Cambodia
46
Lesotho
43
Burkina Faso
42
Mozambique
41
Germany
37
South Sudan
36
Botswana
35
Colombia
33
Brazil
31
Eswatini/ Swaziland
29
Haiti
27
Venezuela
26
Cameroon
25
West and Central Africa
23
East and Southern Africa
23
Guinea
22
Middle East and North Africa
22
Tajikistan
20
Benin
19
Peru
19
Eastern Europe and Central Asia
19
Paraguay
19
Argentina
19
Yemen
18
Chile
16
Sudan
16
Afghanistan
15
Vietnam
15
Pakistan
15
Albania
14
USA
14
Central African Republic
13
Thailand
12
Bolivia
12
Moldova
12
Georgia
12
China
11
Laos
11
Lebanon
11
Mali
11
Somalia
11
Madagascar
11
Western Pacific Region
10
Armenia
9
North America
9
Sri Lanka
9
North Macedonia
8
Mexico
8
El Salvador
8
Ecuador
8
Niger
6
Jordan
6
United Kingdom
6
Palestine
6
Chad
6
Iraq
6
Turkey
5
Iran
5
Burundi
5
Côte d’Ivoire / Ivory Coast
5
Angola
5
Libya
5
Bhutan
5
Timor Leste/ East Timor
4
Gambia
4
Fiji
4
Kyrgyzstan
4
Uzbekistan
4
Guinea-Bissau
4
Saudi Arabia
4
Jamaica
4
Spain
4
Southern Africa
4
Papua New Guinea
4
Egypt
4
Romania
4
Poland
4
Serbia
3
Kazakhstan
3
Morocco
3
Uruguay
3
France
3
Belarus
3
Djibouti
3
Greece
3
Honduras
3
Switzerland
2
Canada
2
Singapore
2
Estonia
2
Mongolia
2
Qatar
2
Dominican Republic
2
Hungary
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Nicaragua
2
Guatemala
2
North Korea
1
Australia
1
Togo
1
Congo-Brazzaville
1
Bulgaria
1
Mauritania
1
Italy
1
Ireland
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3132
Clinical Guidelines
666
Public Health
376
Women & Child Health
341
Key Resources
277
Capacity Building
146
Pharmacy & Technologies
89
Annual Report MEDBOX
2
Toolboxes
HIV
880
Mental Health
788
TB
681
COVID-19
450
AMR
343
NTDs
312
Pharmacy
241
Caregiver
188
NCDs
171
Ebola & Marburg
144
Malaria
142
Refugee
121
Conflict
121
Planetary Health
120
Disability
116
Rapid Response
105
Global Health Education
86
Health Financing Toolbox
81
Natural Hazards
56
2.0 Rapid Response
42
Zika
37
Cholera
34
Specific Hazards
29
Social Ethics
28
Polio
28
South Sudan
2
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monitoring and evaluation framework and outlines the visi...
Three Years After Enactment of the Drug Quality and Security Act
100 test methods for 100 active pharmaceutical ingredients
For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implementation considerations for different regimens for eli...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
The Ethiopian Food and Drug Administration (EFDA) is mandated, in the proclamation 661/2009, to ensure the safety, quality and efficacy of medicines. To achieve this, the authority has been working on different regulatory activities. The medicine market authorization system is one of the top priorit...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme...
A resource for the continued implementation of the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively
Drug-Resistant Tuberculosis in the WHO European Region 2011-2015
Please download the whole Document (large size 28 MB) directly from the website
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
In November 2022, WHO launched a strategy to address antimalarial drug resistance in Africa, emphasizing the need for stronger surveillance. While regional monitoring networks have been active in other regions, most in Africa have not convened since 2017–2018. To renew collaboration, WHO organized...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
